Goldman Sachs raised the firm’s price target on Edwards Lifesciences (EW) to $104 from $94 and keeps a Buy rating on the shares.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences price target raised to $90 from $85 at UBS
- Edwards Lifesciences price target raised to $84 from $81 at Canaccord
- Edwards Lifesciences upgraded to Outperform at Raymond James
- Edwards Lifesciences Reports Strong Earnings and Growth
- Edwards Lifesciences price target raised to $92 from $88 at Evercore ISI